GDC-0425

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 205840

CAS#: 1200129-48-1

Description: GDC-0425, also known as RG7602. is an oral, selective Chk1 inhibitor. GDC-0425 enhances gemcitabine (gem) efficacy in tumor xenograft models. Greater chemopotentiation is observed in cancer cell lines lacking p53 activity. GDC-0425 blocks the function of a protein called checkpoint kinase 1 (Chk1). GDC-0425 was safe and yielded responses in patients with a variety of cancer types, including triple-negative breast cancer, melanoma, and cancer of unknown primary, according to data from a phase I clinical trial presented at the AACR Annual Meeting 2015, held April 18-22.

Chemical Structure

img
GDC-0425
CAS# 1200129-48-1
Handing Instruction

Theoretical Analysis

MedKoo Cat#: 205840
Name: GDC-0425
CAS#: 1200129-48-1
Chemical Formula: C18H19N5O
Exact Mass: 321.159
Molecular Weight: 321.384
Elemental Analysis: C, 67.27; H, 5.96; N, 21.79; O, 4.98

Size Price Shipping out time Quantity
Inquire bulk and customized quantity
Pricing updated 2021-03-01. Prices are subject to change without notice.

GDC-0425 is not in stock, but may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Synonym: GDC0425; GDC-0425; GDC 0425; RG7602; RG-7602; RG 7602.

IUPAC/Chemical Name: 5-((1-ethylpiperidin-4-yl)oxy)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile

InChi Key: XEZLBMHDUXSICI-UHFFFAOYSA-N

InChi Code: InChI=1S/C18H19N5O/c1-2-23-8-5-12(6-9-23)24-17-14(10-19)21-11-15-16(17)13-4-3-7-20-18(13)22-15/h3-4,7,11-12H,2,5-6,8-9H2,1H3,(H,20,22)

SMILES Code: N#CC1=NC=C2C(C3=CC=CN=C3N2)=C1OC4CCN(CC)CC4

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>5 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Handling Instructions:
View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 321.384 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

 1: Ding X, Chen Y, Sahasranaman S, Shi Y, McKnight J, Dean B. A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasma. Biomed Chromatogr. 2016 Jun 1. doi: 10.1002/bmc.3775. [Epub ahead of print] PubMed PMID: 27245274.

2. Development of an Expedient Process for the Multi-Kilogram Synthesis of Chk1 Inhibitor GDC-0425. Andreas Stumpf*†, Zhigang Ken Cheng†, Brian Wong†, Mark Reynolds†, Remy Angelaud†, James Girotti‡, Alan Deese‡, Christine Gu‡, and Lewis Gazzard. †Small Molecule Process Chemistry, ‡Small Molecule Analytical Chemistry, §Department of Discovery Chemistry, Genentech, A member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States Org. Process Res. Dev., 2015, 19 (6), pp 661–672. DOI: 10.1021/acs.oprd.5b00105

img

GDC-0425



Additional Information